Bicycle Therapeutics (BCYC) Form 3: Director Hoppenot Reports No Shares
Herve Hoppenot submitted an Initial Statement of Beneficial Ownership (Form 3) for Bicycle Therapeutics plc (BCYC) reporting the event date 09/08/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Herve Hoppenot submitted an Initial Statement of Beneficial Ownership (Form 3) for Bicycle Therapeutics plc (BCYC) reporting the event date 09/08/2025. The filing identifies Mr. Hoppenot as a Director and states no securities are beneficially owned by him. The form is signed on behalf of the reporting person by an attorney-in-fact, Travis Thompson, dated 09/10/2025. The filing contains no equity holdings or derivative positions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the Form 3 filed for Bicycle Therapeutics (BCYC) disclose?
Does the filing show any stock or option holdings for Hoppenot at BCYC?
When was the Form 3 signed and by whom?
What is the reporting relationship of Herve Hoppenot to BCYC?
Is this a joint filing or filed by one reporting person?
AI-generated analysis. How Rhea-AI works. Not financial advice.